Xilio Therapeutics (XLO) announced that it will implement a 1-for-14 reverse stock split of the issued shares of the company’s common stock, effective on March 13, 2026.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XLO:
- Xilio Therapeutics Updates Investor Presentation on I-O Strategy
- Xilio Therapeutics announces inducement grants
- XLO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Xilio Therapeutics Shareholders Approve Flexible Reverse Stock Split
- Xilio Therapeutics Prices Pre-Funded Warrant Offering Financing